T1D Clinical Studies

In this episode, Todd Brusko, PhD, Laura Jacobsen, MD, and Mike Haller, MD, all from University of Florida join us in a panel style think tank to discuss ATG - Clinical History, Mechanistic Insights, & Future Directions for Type 1 Diabetes Treatment.

IDS 2026 Debate - The next phase of clinical trials of disease-modifying therapy should focus on new-onset and not preclinical T1D.

Debate Moderators: Maria Craig & James Johnson
Affirmative Team: John Wentworth & Laura Jacobsen
Negative Team: Colin Dayan & Jamie Felton

Part of our New Series: Clinical Trial Think Tank

A monthly Sugar Science live and recorded video podcast featuring interviews/presentations from Principal Investigators about new clinical trials in the T1D space. The intended audience consists of members of the T1D research community, referring physicians and potential trial participants, and the structure will attempt to balance scientific rigor with accessible explanations.

In this episode, Benjamin Nwosu joins us to discuss Vitamin D & Type 1 Diabetes.

This video is private.

This video is private.

In this episode, Rupi Vasavada joins us to discuss the new enrolling clinical trial of Denosumab for Type 1 Diabetes.

#clinicaltrial #t1dclinicaltrial #type1diabetes #type1diabetesawareness #type1diabetesclinicaltrial #denosumab #enrollingtrial #science #medicine #diabetes #diabetesclinicaltrial

In this episode, Toby Coates joins us to discuss the 12 months results of the first in human INCEPTR study.

In this episode, Ulf Hannelius joins us to discuss translating genetic insights into clinical progress - the evolution of Diamyd Medical's antigen-specific immunotherapy.

#type1diabetes #t1d #thinktank #diabetes #diabetesresearch #research #novel #diamydmedical #diamyd #antigenimmunotherapy #antigen #clinicalprogress #type1diabetesresearch

In this episode, Drs. Todd Brusko, Mike Haller, Laura Jacobsen and Melanie Shapiro join us to discuss the clinical trials roadmap.

In this episode, Sonja Schrepfer MD PhD and Per-Ola Carlsson MD PhD from Sana Biotech discuss update on first in-human study of hypo immune islet cell transplantation in type 1 diabetes.

At this remote site visit with Indiana University SOM we discuss Type 1 Diabetes Moonshot at IU including discussions about pathology, biomarkers, and clinical translation.

#type1diabetes #type1diabetesresearch #mRNA #riskmarkers #riskscore #biomarkers #HLA #haplotypes #diabetesrisk #diabetesriskscore

In this episode, Emmanuel Bosi discusses the Italian law on screening for type 1 diabetes and celiac disease in the general pediatric population: an update fall 2024.

#asktheexpert #ATE #type1diabetes #t1d #t1dresearch #diabetesresearch #novel #diabetes #italianlaw #screening #celiacdisease #generalpediatrics #fall2024

Join us for the site visit at Vanderbilt School of Medicine as we talk to:
Moderator: Al Powers, MD
Daniel Moore, MD PhD
Bill Russell, MD

In this episode, Tarun Pant discusses monocyte populations in type 1 diabetes families exhibit high activity and subset abundances that correlation with clinical progression

In this episode, Alessandra Petrelli discusses a multi-omics integration approach relying on circulating factors does not discern endotypes in childhood type 1 diabetes.

#asktheexpert #ATE #endotypes #type1diabetes #t1d #t1dresearch #diabetesresearch #novel #diabetes #childhooddiabetes #omics #multiomics #t1dendotypes

Dr. Lowri Allen joins us to discuss relative maternal protection against T1D in offspring as compared with paternal disease!

#science #t1d #genetics #epigenetics #asktheexpert #medicaleducation #type1diabetes #methylation

In this episode, Kagan Ege Karakus, MD, joins us to discuss Tirzepatide use in T1D.

#Tirzepatide #Type1Diabetes #T1D #DiabetesManagement #HbA1c #BodyMassIndex #BMI #ContinuousGlucoseMonitoring #CGM #TimeInRange #TIR #TimeInTightTargetRange #TITR #DiabetesResearch #GLP1RA #GlucagonLikePeptide #Efficacy #Safety #ClinicalStudy #MedicalResearch #DiabetesCare

In this episode, Anath Shalev discusses TIX100 - a novel oral T1D drug - gets IND approval from FDA.

#FDAapproval #TIX100 #clinicaltrials #T1Dtreatment #T1Ddrug #asktheexpert #t1d ##novel #science #noveldrug

In this episode, Inna Starskaia in the lab of Dr. Riitta Lahesmaa discusses distinct cellular immune responses in children en route to type 1 diabetes with different first-appearing autoantibodies.


#novel #asktheexpert #ATE #T1D #diabetes #type1diabetes #human #science #novel #immuneresponse #autoantibodies @zntransporter #autoantibodiesinchildren #turku #TurkuBioscienceCentre